Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2
University of Rochester
University of Rochester
The First Affiliated Hospital of Zhengzhou University
DEKA Biosciences
Second Xiangya Hospital of Central South University
Celldex Therapeutics
Institut Paoli-Calmettes
Tang-Du Hospital
Aduro Biotech, Inc.
ChineseAMS
Biotech Pharmaceutical Co., Ltd.
University of Alabama at Birmingham
University of Chicago
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center